Finch Therapeutics Raises $36 Million Series B, Bringing Total to $77 Million Post author:Sam Post published:February 28, 2018 Post category:BioPharma Finch Therapeutics closed on an oversubscribed Series B financing worth $36 million. Source: BioSpace You Might Also Like Atlas Genetics Taps Life Sciences Vet as New CEO October 2, 2017 Pharma Giant Bristol-Myers Squibb Plans Layoffs, Effective Oct. 6 August 9, 2017 Meet the 6 Powerful Bay Area Biotech VCs You've Never Heard About November 16, 2017
